Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Poliomyelitis"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Poliomyelitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Safety and Immunogenicity of IPOVAC in Young Children
Condition: Poliomyelitis
Interventions: Biological: IMOVAC-POLIO;   Biological: IPOVAC 1.5:5:5;   Biological: IPOVAC, 3:10:10;   Biological: IPOVAC, 6:20:20
2 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Monovalent OPV2 in Children Aged 1 to 5 Years in Lithuania
Condition: Poliomyelitis
Intervention: Biological: Sabin mOPV2
3 Not yet recruiting A Study to Evaluate Safety and Immunogenicity of tOPV in 1 to 5 Years and at 6 Weeks of Age
Condition: Poliomyelitis
Intervention: Biological: Oral Polio Vaccine
4 Recruiting L-Citrulline in Patients With Post-Polio Syndrome
Condition: Post-Polio Syndrome
Interventions: Drug: 15g L-citrulline daily p.o.;   Drug: Placebo
5 Recruiting A Clinical Study Comparing Safety and Immunogenicity of Bivalent Oral Polio Vaccine (bOPV) of Bilthoven Biologicals (BBio) With a Licensed bOPV
Condition: Immune Response to Oral Polio Vaccine
Interventions: Biological: Part 1 study - BBio bOPV;   Biological: Part 2 study - BBio bOPV Lot 1;   Biological: Part 2 study - BBio bOPV Lot 2;   Biological: Part 2 study - BBio bOPV Lot 3;   Biological: Part 2 study - Licensed bOPV;   Biological: Part 1 study - Licensed bOPV
6 Recruiting Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine
Condition: Poliomyelitis
Interventions: Biological: Single-dose regimen of high dosage investigational sIPV;   Biological: Single-dose regimen of medium dosage investigational sIPV;   Biological: Three-dose regimen of high dosage investigational sIPV;   Biological: Three-dose regimen of medium dosage investigational sIPV;   Biological: Three-dose regimen of low dosage investigational sIPV;   Biological: Three-dose regimen of commercialized sIPV;   Biological: Three-dose regimen of commercialized IPV
7 Recruiting Study of the Efficacy and Safety of Immune Globulin Intravenous (Human) Flebogamma® 5% DIF in Patients With Post-polio Syndrome
Condition: Post-polio Syndrome
Interventions: Biological: Flebogamma 5% DIF;   Other: Placebo
8 Not yet recruiting A Campaign-based ID fIPV Administration Trial
Condition: Poliomyelitis
Interventions: Device: ID adaptor;   Device: ID Jet Injector (Tropis, Pharmajet);   Device: Needle and syringe
9 Recruiting Fractional Inactivated Poliovirus Vaccine Booster and Rotavirus Study
Condition: Poliomyelitis
Interventions: Biological: IPV at 14 and 22 weeks of age, Rotarix;   Biological: IPV at 14 and 22 weeks of age, RotaTeq;   Biological: IPV at 14 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 14 and fIPV at 22 weeks, RotaTeq;   Biological: IPV at 6 and fIPV at 22 weeks, Rotarix;   Biological: IPV at 6 and fIPV at 22 weeks, RotaTeq;   Biological: fIPV at 6-14-22 weeks of age, Rotarix;   Biological: fIPV at 6-14-22 weeks of age, RotaTeq
10 Recruiting Immunogenicity and Safety Study of Infanrix Hexa in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Acellular Pertussis;   Tetanus;   Poliomyelitis;   Diphtheria
Interventions: Biological: Infanrix hexa;   Drug: Prevnar13
11 Not yet recruiting A Study to Evaluate the Safety and Immunogenicity of Oral Polio Vaccine Type 2 in Infants and Children
Condition: Adverse Event Following Immunisation
Intervention: Biological: SABIN monovalent OPV2
12 Recruiting Comparing Functional Outcomes in Individuals Using Micro-processor Controlled Orthosis Versus Stance Control Orthosis
Conditions: Spinal Cord Injuries;   Poliomyelitis;   Post-polio Syndrome;   Arthritis;   Lower Motor Neurone Lesion
Interventions: Device: C-brace;   Device: Stance control orthosis
13 Recruiting Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS
Conditions: Diphtheria;   Tetanus;   Pertussis;   Poliomyelitis
Interventions: Biological: DTaP-IPV combination vaccine;   Biological: DTaP vaccine and IPV vaccine
14 Recruiting Extramembranous and Interosseous Technique of Tibialis Posterior Tendon Transfer
Conditions: Muscle Injury;   Nerve Injury;   Poliomyelitis;   Leprosy;   Cerebral Palsy
Interventions: Procedure: Interosseous route of TPTT;   Procedure: Extra membranous route of TPTT
15 Not yet recruiting Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery
Conditions: Diphtheria;   Hepatitis B;   Acellular Pertussis;   Haemophilus Influenzae Type b;   Tetanus;   Poliomyelitis
Intervention: Biological: Infanrix hexa
16 Recruiting Enhance Wellness for Individuals With Long-Term Physical Disabilities
Conditions: Multiple Sclerosis;   Muscular Dystrophy;   Post-polio Syndrome;   Spinal Cord Injury
Intervention: Behavioral: Enhance Wellness
17 Recruiting PVSRIPO for Recurrent Glioblastoma (GBM)
Conditions: GBM;   Glioblastoma;   Glioma;   Malignant Glioma
Intervention: Biological: PVSRIPO
18 Recruiting Clinical Trial of a Serious Game for Individuals With SCI/D
Conditions: Spinal Cord Injury;   Spinal Cord Involvement;   Spina Bifida;   Transverse Myelitis;   Polio and Post-polio Syndrome;   Syringomyelia;   Spinal Stenosis;   Spinal Neoplasms;   Spinal Cord Diseases
Intervention: Behavioral: SCI Hard
19 Recruiting DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a 2nd Year of Life Booster in HIV-Exposed Infected and Uninfected
Conditions: Diphtheria;   Tetanus;   Pertussis;   Hepatitis B;   Polio;   Human Immunodeficiency Virus Infection
Intervention: Biological: Hexaxim®: DTaP-IPV-HB-PRP-T Combined Vaccine

Study has passed its completion date and status has not been verified in more than two years.